These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9869491)

  • 1. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
    Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
    Pugsley MK; Saint DA; Penz MP; Walker MJ
    Br J Pharmacol; 1993 Dec; 110(4):1579-85. PubMed ID: 8306104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker.
    Walker MJA; Hayes ES; Saint DA; Adaikan G; Abraham S; Goldin AL; Beatch GN; MacLeod BA; Wall RA; Pugsley MK
    Biomed Pharmacother; 2018 Oct; 106():510-522. PubMed ID: 29990839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
    Pugsley MK; Saint DA; Walker MJ
    Eur J Pharmacol; 1994 Aug; 261(3):303-9. PubMed ID: 7813552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes.
    Pugsley MK; Yu EJ; Goldin AL
    Gen Pharmacol; 2000 Jun; 34(6):417-27. PubMed ID: 11483291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac electrophysiological effects of sparteine and its analogue BRB-I-28 in the rat.
    Pugsley MK; Saint DA; Hayes E; Berlin KD; Walker MJ
    Eur J Pharmacol; 1995 Dec; 294(1):319-27. PubMed ID: 8788447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological mechanisms for antiarrhythmic efficacy and positive inotropy of liriodenine, a natural aporphine alkaloid from Fissistigma glaucescens.
    Chang GJ; Wu MH; Wu YC; Su MJ
    Br J Pharmacol; 1996 Aug; 118(7):1571-83. PubMed ID: 8842417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives.
    Pugsley MK; Yong SL; Goldin AL; Hayes ES; Walker MJA
    Eur J Pharmacol; 2019 Feb; 844():241-252. PubMed ID: 30571955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RSD1000: a novel antiarrhythmic agent with increased potency under acidic and high-potassium conditions.
    Yong SL; Xu R; McLarnon JG; Zolotoy AB; Beatch GN; Walker MJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):236-44. PubMed ID: 10087010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.
    Cheng L; Ma S; Wei LX; Guo HT; Huang LY; Bi H; Fan R; Li J; Liu YL; Wang YM; Sun X; Zhang QY; Yu SQ; Yi DH; Ma XL; Pei JM
    Heart Vessels; 2007 Sep; 22(5):335-44. PubMed ID: 17879026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel blocking and antiarrhythmic actions of the novel arylpiperazine rsd992.
    Hayes ES; Pugsley MK; Goldin AL; Walker MJ
    Pharmacol Res; 2002 Jul; 46(1):19-27. PubMed ID: 12208117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine.
    Pugsley MK; Walker MJ; Saint DA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KC8851, a tedisamil analogue with mixed channel blockade, exhibits antiarrhythmic properties against ischemia- and electrically-induced arrhythmias.
    Xu R; Abraham S; McLarnon JG; Walker MJ
    Life Sci; 1997; 61(3):237-48. PubMed ID: 9217283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piceatannol, a derivative of resveratrol, moderately slows I(Na) inactivation and exerts antiarrhythmic action in ischaemia-reperfused rat hearts.
    Chen WP; Hung LM; Hsueh CH; Lai LP; Su MJ
    Br J Pharmacol; 2009 Jun; 157(3):381-91. PubMed ID: 19371352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of kappa and Delta opioid agonists on premotor cardiac vagal neurons in the nucleus ambiguus.
    Wang X; Dergacheva O; Griffioen KJ; Huang ZG; Evans C; Gold A; Bouairi E; Mendelowitz D
    Neuroscience; 2004; 129(1):235-41. PubMed ID: 15489045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant.
    Chen WP; Su MJ; Hung LM
    Eur J Pharmacol; 2007 Jan; 554(2-3):196-204. PubMed ID: 17107672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.